3Manz R A,Hoyer B,Moser K.The role of long-lived plasma cells in autoimmune diseases[J].Ann Rheum Dis,2005,64(3):146.
4Mumtaz I M,Hoyer B F,Panne D,et al.Long-lived plasma cells in lupusmice survive therapy with high doses of ghcocorticoids and cyclophosphamide[J].Ann Rheum Dis,2007,66(2):311.
5DiLillo D J,Hanmguchi Y,Ueda Y.Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice[J].Immunol,2008,180:361-371.
6Sze D M,Toellner K M,Garcia-de-Vinuesa C,et al.Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival[J].Exp Med,2000,192(6):813-821.
7Watts R G.Idiopathic thrombocytopenic purpura:a 10-year natural history study at the childrans hospital of Alabama[J].Clin Pediatr (Phila),2004,43(8):691-702.
8Wang JC, Wang A. Plasma soluble interleukin-2 receptor in patientswith primary myelofibrosis. Br J Haernatol, 1994; 86: 380 - 382
9Cimino G, Amadori S, Cava MC, et al. Serum interleukin-2 ( IL-2), soluble interleulkin-2 receptor and tumor necrosis factor α levels are significantly increased in acute myeloid leukemia patients. Leukemia, 1991; 5: 32 - 35
10Zwierzina H, Herold M, Schollenberger S, et al. Detection of solu ble IL-2 receptor in the serum of patients with myelodysplastic syndrome: induction under therapy with GM-CSF. Br J Haematol,1991; 79: 438 - 443